Using a mobile app to help Veterans with suicidal thoughts
Official title: Pilot Randomized Controlled Trial of the Mobile Intervention for Suicidal Thoughts
Funded at Durham VA Medical Center · NIH-11052365 · Data updated 2026-11-12
This study is testing a helpful mobile app for Veterans who are having thoughts of suicide, to see if it can change negative feelings and beliefs while they also get regular treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Durham VA Medical Center NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project start | April 1, 2025 |
| Project end | March 31, 2027 |
| Funding year | 2025 |
| NIH project number | 1I21RX005137-01A1 |
| Project ID | NIH-11052365 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Veterans experiencing suicidal ideation.
✕Less likely to help
Patients who are not Veterans or those without suicidal thoughts may not benefit from this research.
What this research studies
This research investigates the use of a mobile health intervention designed to help Veterans who are experiencing suicidal thoughts. The Mobile Intervention for Suicidal Thoughts (MIST) aims to modify harmful beliefs associated with suicide, such as feelings of hopelessness and burdensomeness. In a pilot trial, 50 Veterans will be randomly assigned to receive either the MIST intervention alongside standard treatment or standard treatment alone. The study will assess how acceptable and feasible this mobile intervention is for Veterans.
Why it matters
Potential benefit: If successful, this research could provide an innovative and accessible tool for reducing suicidal thoughts among Veterans.
How similar studies have gone: Previous research has shown promise in using mobile health interventions for mental health support, indicating potential success for this approach.
Where this research is happening
-
Durham VA Medical Center
Durham, United States Active
Researchers
- Principal investigator: Dillon, Kirsten Hawkins — Durham VA Medical Center
- Study coordinator: Dillon, Kirsten Hawkins
Related research
Other NIH-funded projects on the same topics.
-
Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure
A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.
-
Shorter antifungal treatment for kids with candidemia
A multi-center pediatric trial tests whether a shorter, 7 extra days of antifungal therapy after an initial 7 days is just as good as the standard 14-day approach for kids with candidemia who are improving on echinocandin therapy.
-
Short Course vs Standard Course Antifungal Therapy for Pediatric Candidemia
This study tests whether a shorter 7-day total antifungal treatment after an initial 7 days of echinocandin therapy is as effective as the usual 14-day course for children with candidemia.
-
Shorter antifungal treatment for kids with candidemia
A multi-center study tests whether kids with candidemia can finish treatment earlier after an initial week of antifungal therapy than the standard two weeks total.
-
Shorter antifungal treatment for kids with candidemia
This study tests whether children with candidemia can finish treatment after 7 days of an echinocandin if they are improving, instead of completing a full 14 days.
-
Shorter antifungal course for kids with candidemia
A multi-center study tests whether 7 extra days of antifungal therapy after an initial week of treatment can be shortened safely for children with candidemia.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.